In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs ...Middle East

Sentinel-Tribune - News
In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs
A recent boom in psychedelic research has given way to a bumper crop of startups seeking to harness the potential of mind-altering drugs for treating depression, addiction and other conditions. In this crowded field, Vancouver-based Filament Health has a unique approach: extracting drugs like psilocybin and mescaline from natural sources, including mushrooms and cacti, rather than synthesizing the ingredients in a laboratory. Filament is studying its mushroom-based psilocybin as a treatment for opioid and stimulant use disorder. And more than a dozen other companies and academic centers are using the company’s drugs in trials of depression, chronic pain and other disorders. Filament CEO Benj

Read More Details
Finally We wish PressBee provided you with enough information of ( In crowded field of psychedelic startups, Filament CEO makes case for ‘natural’ drugs )

Also on site :